EDITORIAL
TIMP-1 in asthma
TIMP-1 in asthma: guilty by association
Correspondence to:
Correspondence to:
Dr S R Johnson
Division of Therapeutics and Molecular Medicine, University Hospital, Queens Medical Centre, Nottingham NG7 2UH, UK; simon.johnson@nottingham.ac.uk
A novel TIMP-1 polymorphism is associated with asthma in women
Keywords: matrix metalloproteinase-9 (MMP-9); tissue inhibitor of metalloproteinases-1 (TIMP-1); asthma; polymorphism
| The first 150 words of the full text of this article appear below. |
Over the last few years there has been increasing interest in the matrix metalloproteinases (MMPs) in asthma. The MMPs are a family of over 20 zinc dependent endopeptidases with a range of substrate specificities. Although originally classified into gelatinases, stromolysins, collagenases, and matrilysins by their ability to cleave extracellular matrix components, it is now clear that MMPs have an increasing range of other functions. Of potential relevance to asthma is the release and activation of growth and angiogenic factors including transforming growth factor ß (TGFß)1 and vascular endothelial growth factor (VEGF),2 apoptosis by release of Fas ligand,3 and activation of cell surface receptorscollectively resulting in effects on cell differentiation, survival, proliferation, and migration.4 MMP activity is tightly regulated at several levels. Gene transcription is enhanced by growth factors, cytokines and adhesion molecules and downregulated by TGFß and corticosteroids.5 MMPs are secreted as zymogens which require activation by
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
